AR004284A1 - Derivados de aminometil-2,3,8,9-tetrahidro-7h-1,4-dioxino-2,3-e-indol-8-onas y el uso de los mismos para la manufactura de un medicamento - Google Patents

Derivados de aminometil-2,3,8,9-tetrahidro-7h-1,4-dioxino-2,3-e-indol-8-onas y el uso de los mismos para la manufactura de un medicamento

Info

Publication number
AR004284A1
AR004284A1 ARP960105059A ARP960105059A AR004284A1 AR 004284 A1 AR004284 A1 AR 004284A1 AR P960105059 A ARP960105059 A AR P960105059A AR P960105059 A ARP960105059 A AR P960105059A AR 004284 A1 AR004284 A1 AR 004284A1
Authority
AR
Argentina
Prior art keywords
optionally substituted
defined above
alkyl
hydrogen
heteroaryl
Prior art date
Application number
ARP960105059A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR004284A1 publication Critical patent/AR004284A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Los compuestos de fórmula (I), en donde R1 y R2 son, independientemente, hidrógeno, alquilo, fenilo o bencilo; o R1 y R2 tomados juntos son bencilidenoopcionalmente substituido con R3 como se define a continuación, o alquilideno, o R1 y R2tomado s juntos con el carbono al cual están unidos, forman unaporción de carbonilo o un grupo cicloalquilo; R3 es hidrógeno, hidroxi, halo, trifluormetilo, trifluormetoxi, alquilo, alcoxi, aralcoxi, alcanoiloxi, amino,mono o di-alquilamino,alcanamido, o alcanosulfonamido; R4 es hidrógeno o alquilo; m es un entero 0, 1 ó 2; n es un entero de 0 a 6 inclusive; Z eshidrógeno, hidroxi, alquilo, alquenilo, alquinilo, alcoxi, cicloalquilo, policiclo-alquilo, fenilo opcionalmentesubstituido c on R3 como se defineanteriormente, fenoxi opcionalmente substituido con R3 como se define anteriormente, naftilo opcionalmente substituido con R3 como se defineanteriormente, o naftiloxi opcionalmente substituido con R3 comose define anteriormente, heteroarilo o heteroariloxi, en el que el anillo heterocíclicodel grupo heteroarilo o heteroariloxi es seleccionado de tiofeno, furano, piridina, pirazina, pirimidina, indol, indazol, imidazol, cromano,cumarina,carboestirilo, qu inolina, bencisoxazol, benzoxazol, pirazol, pirrol, tiazol, oxazol, o isoxazol, y el anillo heterocíclico es opcionalmente substituido porR3 como se define con anterioridad; o una sal farmacéuticamente aceptable de losmismos, son útiles en el tratamiento de desórdenes del sistemadopaminérgico.
ARP960105059A 1995-11-06 1996-11-05 Derivados de aminometil-2,3,8,9-tetrahidro-7h-1,4-dioxino-2,3-e-indol-8-onas y el uso de los mismos para la manufactura de un medicamento AR004284A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US728395P 1995-11-06 1995-11-06
US08/730,267 US5756532A (en) 1995-11-06 1996-10-15 Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives

Publications (1)

Publication Number Publication Date
AR004284A1 true AR004284A1 (es) 1998-11-04

Family

ID=26676776

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP960105059A AR004284A1 (es) 1995-11-06 1996-11-05 Derivados de aminometil-2,3,8,9-tetrahidro-7h-1,4-dioxino-2,3-e-indol-8-onas y el uso de los mismos para la manufactura de un medicamento
ARP000104875A AR025698A1 (es) 1995-11-06 2000-09-15 Derivados de la quinolil propil piperidina, su preparacion y las composiciones farmaceuticas que los contienen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP000104875A AR025698A1 (es) 1995-11-06 2000-09-15 Derivados de la quinolil propil piperidina, su preparacion y las composiciones farmaceuticas que los contienen.

Country Status (21)

Country Link
US (2) US5756532A (es)
EP (3) EP0771800A3 (es)
JP (1) JP4311770B2 (es)
KR (1) KR100566678B1 (es)
CN (1) CN1084748C (es)
AR (2) AR004284A1 (es)
AT (1) ATE349450T1 (es)
AU (1) AU701624B2 (es)
CA (1) CA2189524C (es)
CZ (1) CZ291731B6 (es)
DE (1) DE69636801T2 (es)
DK (1) DK1375503T3 (es)
ES (1) ES2277014T3 (es)
HU (1) HU224841B1 (es)
IL (1) IL119565A (es)
MX (1) MX9605367A (es)
NO (1) NO317054B1 (es)
NZ (1) NZ299693A (es)
PT (1) PT1375503E (es)
RU (1) RU2178416C2 (es)
SK (1) SK282168B6 (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9627005D0 (en) * 1996-12-27 1997-02-12 Knoll Ag Therapeutic agents
GB9704948D0 (en) 1997-03-11 1997-04-30 Knoll Ag Therapeutic agents
US6362009B1 (en) 1997-11-21 2002-03-26 Merck & Co., Inc. Solid phase synthesis of heterocycles
US6350773B1 (en) * 1999-12-10 2002-02-26 American Home Products Corporation Therapeutic combinations of (S)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro 7H-1,4-dioxino{2,3-e}indol-8-one and neuroleptics for the treatment or prevention of psychotic disorders
MXPA02005649A (es) * 1999-12-10 2004-09-10 Wyeth Corp Nuevas combinaciones terapeuticas de (s)-2 -(bencilamino -metil)-2, 3, 8, 9-tetrahidro-7h -1, 4-dioxino(2-3 -e]indol-8 -ona y agentes neurolepticos para el tratamiento o prevencion de trastornos psicoticos.
US20060223824A1 (en) * 2000-11-28 2006-10-05 Wyeth Serotonergic agents
US20060287335A1 (en) * 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
US6458802B1 (en) 2001-03-14 2002-10-01 Wyeth Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino [2,3-f]quinoline
US6803368B2 (en) 2001-04-25 2004-10-12 Wyeth Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diaza-cyclopenta[a]naphthalene
CA2445581A1 (en) * 2001-04-26 2002-11-07 Jonathan Laird Gross Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoxaline
US6821981B2 (en) 2001-04-26 2004-11-23 Wyeth Azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]-quinoline as 5-HT1A antagonists
WO2002088129A1 (en) * 2001-04-26 2002-11-07 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline
US6861427B2 (en) * 2001-04-26 2005-03-01 Wyeth Azabicyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline as 5-HT1A antagonists
US6800641B2 (en) 2001-04-26 2004-10-05 Wyeth Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-2,3-diaza-cyclopenta[a]naphthalene
US6800648B2 (en) 2001-04-26 2004-10-05 Wyeth Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-1,6,9-trioxa-3-AZA-cyclopenta[a]naphthalen-2-one
DE60206048T2 (de) * 2001-04-26 2006-07-13 Wyeth Antidepressive (sssri) azaheterocyclylmethylderivate von 7,8-dihydro-3h-6,9-dioxa-1,3-diazacyclopenta [a] naphthalin
US6861434B2 (en) * 2001-04-26 2005-03-01 Wyeth Antipsychotic aminomethyl derivatives of 1,3,7,8-tetrahydro-6,9-dioxa-1,3-diaza-cyclopenta[a]-naphthalen-2-one
US7008944B2 (en) * 2001-04-26 2006-03-07 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-Dioxino[2,3-f]quinoxaline
US6927226B2 (en) 2001-04-26 2005-08-09 Wyeth Antidepressant azaheterocyclymethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diazacyclopenta[a]naphthalene
US6800642B2 (en) 2001-04-26 2004-10-05 Wyeth Antipsychotic aminomethyl derivatives of 7,8-dihydro-2,6,9-trioxa-3-aza-cyclopenta[a]naphthalene
US6555560B2 (en) 2001-04-30 2003-04-29 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
US6906206B2 (en) 2001-04-30 2005-06-14 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
CA2447150A1 (en) * 2001-05-17 2002-11-21 Wyeth Processes for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f] quinoline
US6541502B1 (en) 2001-07-20 2003-04-01 Wyeth 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity
US6541501B2 (en) 2001-07-20 2003-04-01 Wyeth 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity
WO2003010169A1 (en) * 2001-07-25 2003-02-06 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 7, 8-dihydro-6h-5-oxa-1-aza-phenanthrene
US7135479B2 (en) 2002-09-12 2006-11-14 Wyeth Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
US6800637B2 (en) * 2002-09-12 2004-10-05 Wyeth Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
CN100352820C (zh) * 2002-09-12 2007-12-05 惠氏公司 抗抑郁的杂环稠合的苯并二噁烷的氮杂环甲基衍生物
US6939877B2 (en) * 2002-09-12 2005-09-06 Wyeth Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
US7153849B2 (en) * 2002-09-12 2006-12-26 Wyeth Antidepressant arylpiperazine derivatives of hetrocycle-fused benzodioxans
SG147450A1 (en) * 2003-10-29 2008-11-28 Wyeth Corp Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
CA2597616A1 (en) 2005-02-17 2006-08-24 Wyeth Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
JP2008531694A (ja) * 2005-03-01 2008-08-14 ワイス 結晶性および非晶性４−シアノ−ｎ−｛（２ｒ）−２−［４−（２，３−ジヒドロ−ベンゾ［１，４］ジオキシン−５−イル）−ピペラジン−１−イル］−プロピル｝−ｎ−ピリジン−２−イル−ベンズアミド塩酸塩
PE20061327A1 (es) * 2005-04-22 2007-01-02 Wyeth Corp Combinaciones de derivados de benzofurano y un antidepresivo para el tratamiento o la prevencion de la depresion
TW200811182A (en) * 2006-05-25 2008-03-01 Wyeth Corp Oxindoledioxans, synthesis thereof, and intermediates thereto
US8466296B2 (en) * 2007-03-26 2013-06-18 Ligand Pharmaceuticals Compounds and processes for preparing substituted aminomethyl-2,3,8,9-tetrahydro-7H-1,4-dioxino[2,3-e]indol-8-ones
JP5755217B2 (ja) * 2009-03-30 2015-07-29 トランステック・ファーマ，エルエルシー 置換アゾアントラセン誘導体、その医薬組成物とその使用の方法
RU2554883C1 (ru) * 2014-05-27 2015-06-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) Применение производных ацеталей пиридоксина в качестве антагонистов пуринорецепторов
RU2554885C1 (ru) * 2014-05-27 2015-06-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) Антагонисты пуринорецепторов на основе новых производных пиридоксина

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991013872A1 (en) * 1990-03-15 1991-09-19 The Upjohn Company Therapeutically useful heterocyclic indole compounds
US5166367A (en) * 1991-06-21 1992-11-24 American Home Products Corporation Antipsychotic benzodioxan derivatives
US5189171A (en) * 1991-06-21 1993-02-23 American Home Products Corporation Antipsychotic benzodioxan derivatives
US5126366A (en) * 1991-06-21 1992-06-30 American Home Products Corporation Aminophenoxyalkyl derivatives of benzodioxan
DE4135474A1 (de) * 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
US5235055A (en) * 1992-09-02 1993-08-10 American Home Products Corporation Antipsychotic quinoline derivatives of benzodioxanmethylamine
US5245051A (en) * 1992-09-03 1993-09-14 American Home Products Corporation Antipsychotic chroman derivatives of benzodioxanmethylamine

Also Published As

Publication number Publication date
CN1084748C (zh) 2002-05-15
JP4311770B2 (ja) 2009-08-12
AR025698A1 (es) 2002-12-11
NO964686D0 (no) 1996-11-05
CZ291731B6 (cs) 2003-05-14
DE69636801D1 (de) 2007-02-08
NZ299693A (en) 1997-09-22
KR970027068A (ko) 1997-06-24
EP0771800A3 (en) 1998-01-28
CA2189524C (en) 2007-05-01
EP1375503B1 (en) 2006-12-27
RU2178416C2 (ru) 2002-01-20
DE69636801T2 (de) 2007-04-26
JPH09249671A (ja) 1997-09-22
CN1155546A (zh) 1997-07-30
EP0771800A2 (en) 1997-05-07
AU701624B2 (en) 1999-02-04
SK141496A3 (en) 1997-08-06
EP1726592A1 (en) 2006-11-29
CZ324196A3 (en) 1997-12-17
NO317054B1 (no) 2004-08-02
AU7055396A (en) 1997-05-15
KR100566678B1 (ko) 2006-11-30
SK282168B6 (sk) 2001-11-06
US5756532A (en) 1998-05-26
EP1375503A1 (en) 2004-01-02
HUP9603057A2 (en) 1997-05-28
IL119565A0 (en) 1997-03-18
HU224841B1 (en) 2006-03-28
NO964686L (no) 1997-05-07
HUP9603057A3 (en) 1998-12-28
CA2189524A1 (en) 1997-05-07
DK1375503T3 (da) 2007-01-22
US5962465A (en) 1999-10-05
IL119565A (en) 2002-11-10
PT1375503E (pt) 2007-03-30
ES2277014T3 (es) 2007-07-01
ATE349450T1 (de) 2007-01-15
MX9605367A (es) 1997-10-31
HU9603057D0 (en) 1996-12-30

Similar Documents

Publication Publication Date Title
AR004284A1 (es) Derivados de aminometil-2,3,8,9-tetrahidro-7h-1,4-dioxino-2,3-e-indol-8-onas y el uso de los mismos para la manufactura de un medicamento
HUT64326A (en) Process for production indole derivatives and pharmaceutical preparations containing these compounds
RU2006142346A (ru) 3-амино-1-арилпролилиндолы, применяемые в качестве ингибиторов обратного захвата моноаминов
US7671079B2 (en) Sulfonyltetrahydro-3H-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands
RU95105587A (ru) Оптически чистые соединения пиридинилметил сульфинил-1н-бензимидазола, их соли, способы получения, фармкомпозиция, способ лечения
HU910128D0 (en) Process for the production of five-membered heterocyclic compounds substituted with indole groups, and process for the production of medical preparations containing such compounds
PT100905A (pt) Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
ATE34984T1 (de) Imidazo-heterocyclische verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
AR046222A1 (es) Composiciones farmaceuticas de liberacion sostenida que incluyen aplindore y sus derivados
HUP0202787A2 (hu) 5-HT1B antagonista piperazinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
KR900016202A (ko) 2개의 헤테로원자를 갖는 5원환을 포함하는 스피로사이클릭 화합물
FR2639349B1 (fr) Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant
NO177007C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive tetrahydrobenzimidazolderivater
US5496950A (en) Use for bis-heterocyclic compounds and pharmaceutical compositions containing same
MX9604687A (es) Procedimiento para la preparacion de derivados de imidazo-benzodiacepina.
ATE698T1 (de) Analgetische 6-acylaminot etrahydro-1,3,5-triazin-2,4-dion-derivate, sie enthaltende pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung.
HUP9700708A2 (hu) N-[(9-pirimido[1,2-a]indolil)-metil-fenil-acetil]-fenil-glicinol-származékok, az ezeket tartalmazó gyógyszerkészítmények, eljárás előállításukra és intermedierjeik
KR930006024A (ko) 이미다조 인돌리진 유도체 및 그의 제조방법
EP0806419A1 (en) Benzoxazole derivatives as serotonin 5-HT3 receptor partial activator
KR940006584A (ko) 멀미 및 구토 치료용 6-헤데로시클릭-4-아미노-1,3,4,5-테트라하이드로벤즈[cd]인돌
ATE18221T1 (de) (1-arylcyclobutyl)(heterocyclyl)methylaminderivate, ihre herstellung und ihre verwendung als arzneimittel.
KR870011152A (ko) 글루타민산 유도체
AR019390A1 (es) Derivados de acidos sulfonilaminofosfinicos y sulfonilaminofosfonicos, procedimiento para su preparacion, compuestos intermediarios, medicamentos, procedimiento para su preparacion y empleo de dichos derivados para la preparacion de un medicamento.
ES8303418A1 (es) Un procedimiento para la preparacion de derivados de benzo (4,5 pinano 2,3c) pirrol.
TW337523B (en) Aminomethyl-2, 3, 8,9-tetrahydro-7H-1, 4-dioxino (2, 3-e)-indol-8-ones and derivatives

Legal Events

Date Code Title Description
FG Grant, registration
FG Grant, registration